Letters Section Editor: Robert M. Golub, MD, Senior Editor.
To The Editor: Dr Bridge and colleagues1 performed a systematic review and meta-analysis of the risks and benefits of antidepressant medications for pediatric psychiatric disorders. It seems misleading to limit the issues of risk and harm to treatment-emergent suicidality, when in actual practice other adverse reactions that make these medications intolerable for young persons occur much more regularly.
Waslick B. Benefits and Harms of Pediatric Antidepressant Medications. JAMA. 2007;298(6):626–627. doi:10.1001/jama.298.6.626-a
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: